Table 6. Pharmacokinetic Parameters of 4, 5, 6, 7, 8, and 1 from an In Vivo Pharmacokinetic Study.
compound | route | dose (mg/kg) | C0 or Cmax (ng/mL) | CLtot (mL/h/kg) | Vdss (mL/kg) | AUC0–8h (ng/mL·hr) | BA (%) |
---|---|---|---|---|---|---|---|
4 | iv | 0.1 | 1543 | 24.3 | 153 | 2961 | |
po | 0.1 | 240 | 1489 | 50.3 | |||
5 | iv | 0.1 | 1743 | 20.6 | 113 | 3708 | |
po | 0.1 | 390 | 2476 | 66.8 | |||
6 | iv | 0.1 | 1718 | 20.6 | 112 | 3726 | |
po | 0.1 | 395 | 2524 | 67.7 | |||
7 | iv | 0.1 | 1337 | 39.7 | 269 | 1746 | |
po | 0.1 | 77 | 350 | 20.1 | |||
8 | iv | 0.1 | 1645 | 26.4 | 123 | 3102 | |
po | 0.1 | 303 | 1918 | 61.8 | |||
1 | iv | 0.1 | 519 | 5.96 | 311 | 2363 | |
po | 0.1 | 235 | 1500 | 63.5 |